EUDA Health (EUDAW) furnishes Form 6-K and press release update

Rhea-AI Filing Summary

EUDA Health Holdings Limited submitted a Form 6-K as a foreign private issuer to furnish a company press release as an exhibit. The report is categorized as an "Other Events" update and is tied to a press release dated September 4, 2025.

The filing is signed on behalf of the company by Interim Chief Financial Officer Vivian Tay, indicating management’s authorization of this disclosure under the Securities Exchange Act of 1934.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-40678

EUDA Health Holdings Limited

(Exact Name of Registrant as Specified in its Charter)

60 Kaki Bukit Place, #03-01

Eunos Techpark, Singapore 415979.

(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: +65 6327 1110.

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Other Events.

On September 4, 2025, EUDA Health Holdings Limited issued the press release filed herewith as Exhibit 99.1.

Exhibits

99.1 Press release dated September 4, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Dated: September 4, 2025
	EUDA Health Holdings Limited
	By:	/s/ Vivian Tay
	Name:	Vivian Tay
	Title:	Interim Chief Financial Officer

FAQ

What is EUDAW EUDA Health Holdings Limited reporting in this Form 6-K?

EUDA Health Holdings Limited is using this Form 6-K to furnish a company press release as an exhibit. The filing is classified as an "Other Events" report, meaning it communicates a corporate development to U.S. investors under the Securities Exchange Act framework.

What type of issuer is EUDAW EUDA Health Holdings Limited in this filing?

EUDA Health Holdings Limited is identified as a foreign private issuer in this report. It files periodic information with the SEC under rules applicable to non-U.S. companies, using forms such as Form 6-K instead of standard domestic issuer forms like Form 8-K.

What event is associated with EUDAW EUDA Health’s September 2025 Form 6-K?

The Form 6-K is associated with an "Other Events" disclosure linked to a press release dated September 4, 2025. That press release is furnished as Exhibit 99.1, making it part of the formal information provided to U.S. markets and regulators.

Who signed the EUDAW EUDA Health Holdings Limited Form 6-K?

The Form 6-K is signed on behalf of EUDA Health Holdings Limited by Vivian Tay, the Interim Chief Financial Officer. This signature confirms the company’s authorization of the information furnished in the report under the Securities Exchange Act requirements.

Where is EUDAW EUDA Health Holdings Limited headquartered according to this Form 6-K?

The report lists EUDA Health Holdings Limited’s principal executive offices at 60 Kaki Bukit Place, #03-01, Eunos Techpark, Singapore 415979. This Singapore address identifies the company’s primary business location as disclosed to investors and regulators in the filing.

What exhibit is included with EUDAW EUDA Health’s Form 6-K filing?

The Form 6-K includes a company press release as Exhibit 99.1. By attaching this press release as an exhibit, EUDA Health Holdings Limited formally furnishes the underlying communication to the SEC and U.S. investors within the foreign issuer reporting framework.